Trial intelligence / Profile preview

ICG Angiography in Microvascular Surgery for Systemic Sclerosis

NCT03155464Phase 4Withdrawn

Sponsor
Duke University
Start
Jun 2017
Primary completion
Jan 2018
Modality
Small Molecules
01

Overview

A Phase 4 trial of indocyanine green in systemic sclerosis (SSc), sponsored by Duke University. Planned start Jun 2017; status: withdrawn.

02

Drugs

indocyanine green
03

Conditions

systemic sclerosis (SSc)

Beyond the preview

Go deeper on NCT03155464.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03155464.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call